Federal Register Notice: FDA is reopening until 5/5 the period for industry organizations to apply to represent, in a non-voting capacity, the interests of the pharmaceutical manufacturing industry and the pharmacy compounding industry on the Pharmacy Compounding Advisory Committee in CDER. This request was originally announced in the 1/13 Federal Register. To view this notice, click here.
